PhotoPharmics

PhotoPharmics is a privately-held, clinical-stage medical device company dedicated to developing next-generation treatments for neurodegenerative diseases through ocular therapy, as well as non-invasive therapies aimed at improving the lives of patients with neurological disorders and addiction. The company’s therapies provide chronobiological treatment for Parkinson’s disease and medical edge-lit devices for treating neurological conditions, enabling healthcare providers to restore health in patients with Parkinson’s disease.